Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists

Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Physiol Rep
Main Authors: Birkhoff, Willem A. J., Heuberger, Jules A. A. C., Post, Titiaan E., Gal, Pim, Stuurman, Frederik E., Burggraaf, Jacobus, Cohen, Adam F.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308108/
https://ncbi.nlm.nih.gov/pubmed/30592183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13924
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki